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Effect of chronic administration of different Bence Jones proteins on rat
kidney. The role of Bence Jones proteins (BJPs) in the genesis of the
renal dysfunction that develops in patients with multiple myeloma is not
clearly defined. We previously evaluated renal function and morphol-
ogy in a unique strain of rats (LOU/rn) bearing tumors which synthe-
sized BJPs with isoelectric points of 5.2, 4.3 and 6.7. Myeloma cast
nephropathy developed in one tumor bearing group (p1 5.2), tubular
necrosis was observed in another (p1 4.3), and renal function and
histology remained normal in a third group (p1 6.7). To see if these renal
outcomes were a function of the BJP being excreted or other factors
which could be present in the tumor bearing animals, we have examined
the effect of chronic intravenous administration of these three BJPs on
renal function and histology in non-tumor—bearing LOU/rn rats. Urine
containing the BJP was collected from tumor bearing rats, sterilized by
passage through a 0.2 j millipore filter, concentrated to 50 mg/mI, and
dialyzed extensively so as to remove material with a molecular weight
< 3500. Chronic indwelling—venous catheters were placed in non-
tumor—bearing LOU/rn rats and these rats were given 100 mg/day for
five days of one of the three BJPs. Polyfructosan clearance (C1,,) was
measured prior to and following the five days of BJP administration.
Renal histology was examined at the completion of the second Ci,,. in
the p1 5,2 group (N = 6), a severe distal nephron cast nephropathy
occurred and C1,, fell from 2.88 0.24 to 0.90 0.17 mi/mm (P <0.002).
In the p1 4.3 group, a less—severe cast nephropathy was observed and
C,,, fell from 2.71 0.15 to 1.80 0.20 ml/min (P < 0.05). In the p1 6.7
group (N 8), renal histology remained largely unaltered and there was
no significant change in C10. These observations provide further and
more direct evidence that the renal response to exposure to different
BJPs is not uniform and that the diversity in renal functional and
pathologic alterations observed in patients with myeloma and Bence
Jones proteinuria may be due to differences in the physicochemical
nature of the individual BJP being excreted.
Renal dysfunction is frequently observed in patients with
multiple myeloma. Up to two thirds of such patients are found
to have a serum creatinine of greater than 1.5 mg% and 10 to
20% develop end—stage renal disease [I]. A number of obser-
vations suggest that Bence Jones proteins (BJP) may play a
critical role in the genesis of this renal dysfunction [2]. The
renal response to exposure to BJP, however, does not appear to
be uniform. While some studies have shown a correlation
between the amount of BJP being excreted and the decrement
in GFR [3, 4], it is clear that patients may excrete large amounts
of certain BJPs for years and yet maintain normal renal function
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[5, 6]. Moreover, among those with Bence Jones proteinuria
and renal dysfunction, a spectrum of renal alterations may be
observed ranging from isolated tubular defects to glomerulop-
athies to severe, chronic renal failure [3, 7, 8]. Renal pathology
in patients with myeloma and chronic renal failure may also
vary. In some patients, a distinctive cast nephropathy
("myeloma kidney") may be observed [9], while in other
patients, tubular atrophy with minimal evidence of cast forma-
tion or intratubular obstruction may be found [3, 10]. This
diversity in renal functional and pathologic alterations observed
in patients with myeloma and Bence Jones proteinuria may be
due to differences in the physicoehemical nature of individual
BJP, the presence or absence of various triggering factors, or
some combination of the above. Alternatively, it may suggest
that factors independent of the BJP may be more important than
the BJP in determining the renal outcome.
In a previous study [111 we examined some of these issues in
a rat model of multiple myeloma. Rats implanted with one of
several different homologous kappa—light—chain (BJP) synthe-
sizing—tumors were kept hydropenic and aciduric. Rats excret-
ing a BJP with api of 5,2 were found to have an elevated serum
creatinine and a distal nephron light—chain cast nephropathy.
Rats excreting the p1 4.3 BJP also had an elevated serum
creatinine, but renal histologic changes were those of acute
tubular necrosis. In contrast to these two groups, rats excreting
the p1 6.7 BJP maintained a normal serum creatinine and renal
histology which was virtually normal. Thus, as in human
myeloma, a spectrum of renal lesions was demonstrable in this
animal model. With this study it was not possible to ascertain
whether the different renal outcomes were actually a function of
the different BJP to which the kidneys were exposed. It is
conceivable that tumor related factors other than the BJP
(degree of tumor infiltration into the body, metabolic effects of
the tumor, etc.) differed among the different tumor groups and
may have contributed to the renal outcomes. In addition,
because each of the three different tumors had unique growth
and BJP production characteristics, the amount of BJP to which
the kidney was exposed and the duration of exposure varied
from group to group. If the nephrotoxie effect was dependent on
the load of BJP presented to the kidney, this could have affected
the outcome. Further, since glomerular filtration [12] and tubu-
lar catabolism [131 of different BJP may vary, comparison of the
amount present in the urine might not accurately reflect the
loads presented to the renal tubules.
The purpose of the present study, therefore, was to control
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for the factors noted above and thereby: a) more directly
establish the role of the BJP in the development of renal failure
in this model; and b) determine if the different renal outcomes
were a function of differences in the BJPs themselves. To
accomplish this, the effect on renal function and morphology
were evaluated in non-tumor—bearing (LOU/rn) rats which were
chronically administered equal amounts of the different BJPs.
Methods
Preparation of the Bence Jones proteins
BJP producing tumors were implanted subcutaneously in
histocompatible LOU/rn rats. When the tumors grew to a size of
2 to 3 cm in diameter, the 24 hour protein excretion, measured
by the Lowry method as modified by Pesce and First [14], was
typically greater than 20 mg and the presence of a BJP spike
could be readily revealed with cellulose acetate electrophoresis.
At this time the rats were placed in metabolic cages, and urine
was collected daily into containers to which sodium azide had
been added as a preservative. Each daily specimen was then
clarified by centrifugation (2000 rpm x 20 mm) and sterilized by
passage through a 0.2 micron Nalgene filter (Sybron Corp.,
Rochester, New York, USA) and then stored at —20°C. When
sufficient quantity of urine was collected, it was thawed,
pooled, and again clarified by centrifugation. The urine was
then concentrated in a membrane concentrator (Amicon Corp.,
Danvers, Massachusetts, USA) to approximately 50 mg/mi. It
was then extensively dialyzed against phosphate buffered saline
(PBS) (spectrapor dialysis tubing 3500 mol wt cutoff (Spectrum
Medical Industries, Los Angeles, California, USA) to remove
the azide and low molecular weight urinary solutes. The final
concentration of the protein was then adjusted to 50 mg/mi.
Urines containing BJP with a p1 of 4.3, 5.2, or 6.7 were all
obtained in this manner. Sodium dodecyl sulfate—polyacryl-
amide gel electrophoresis (SDS-PAGE) was employed to eval-
uate the molecular weights of the proteins present in each of the
three preparations. As was demonstrated in our previous study
[11], the banding appearance was similar for the three prepara-
tions. Each contained one major band with an apparent mol wt
of 24,000. While some contained small amounts of higher mol
wt bands, these appeared to be polymers of the BJP since the
mol wt of these bands was a multiple of 24,000 and when the
urines were evaluated under reducing conditions, only the
24,000 mol wt band was observed. The presence in the urine of
proteins of lower mol wt was not apparent in any of the
preparations with this method.
Animal protocol
LOU/m rats weighing 250 to 300 g and raised in a colony
housed in our lab resources facility were used for these studies.
Silastic catheters were placed in the femoral veins (under
Brevitol anesthesia, Lilly and Co., Indianapolis, Indiana, USA)
to permit administration of the BJP and for use in performing
the clearance studies. These catheters were tunnelled subcuta-
neously and brought out through the skin at the base of the
neck. The catheters were filled with 50 units of heparin to
prevent clot formation. After awakening, the rats were kept in
individual metabolic cages and maintained on a high acid ash,
water restricted diet designed to keep the urine pH at 5.5 to 6.0
and urine osmolality at 2000 to 3000 mOsm/kg water. This is the
same diet as was used in our previous study [11]. After the rats
had been on this diet for two days, they underwent measure-
ment of a baseline glomerular filtration rate (GFR) in the awake
state.
Following completion of the initial GFR measurement, ad-
ministration of the BJP was begun. Each day for five days 100
mg of one of the three BJP (in a volume of 2 ml) was given
intravenously through the silastic catheter. During this time the
rats were maintained on the high acid ash, water restricted diet
as described earlier. Twenty—four hours after the last injection
of the BJP, the GFR was again measured. Following this, the
rats were anesthetized with ether and the kidneys were proc-
essed for morphologic study.
Measurement of GFR in the awake rats were performed as
follows. The rats were lightly anesthetized with ether and
placed in a harness (Model 510 M, Spaulding Medical Products,
Arroyo Grande, California, USA). The silastic femoral vein
catheter was connected to 30 gauge Tygon tubing, and this was
attached to a small animal infusion swivel (Model 375/22;
Instech Lab, Philadelphia, Pennsylvania, USA) to allow free
rotation of the animals. Tygon tubing was also used to connect
the infusion syringe and the other end of the swivel. After
patency of the line was confirmed by blood return, a bolus of
0.17 ml of polyfructosan (mutest, Laevosan—Gesellschaft,
Donau, Austria) was given, followed by a constant infusion of
Ringers solution containing polyfructosan (15%) at 20 jL/min
(Model 975 Harvard pump, Harvard Apparatus, South Natick,
Massachusetts, USA). After the rats awakened, they were
placed in a cage. After a one hour equilibration period, the rats
were again lighty anesthetized with ether, the venous catheter
was disconnected from the infusion tubing, and blood was
obtained for measurement of polyfructosan concentration. To
do this, the contents of the infusion line were withdrawn and
discarded along with 0.1 ml of blood to clear the line of
polyfructosan. The line was then flushed with 0.4 ml of Ringer's
solution and 0.2 ml of blood was withdrawn (after clearing the
tubing of the flush solution). Preliminary studies demonstrated
that the plasma polyfructosan concentrations determined in this
manner in the venous blood were not different from that
measured in arterial blood obtained simultaneously. After the
blood was withdrawn, the lines were reconnected and the
infusion was continued for two hours in the awake animal. A
second blood sample was then obtained and the rat was
returned to his cage. With this method, the steady—state
plasma—polyfructosan level varied by less than 15%. In the
steady—state, the amount of polyfructosan infused equaled the
amount excreted. Thus, the rate of polyfructosan infused may
be used in place of the rate of polyfructosan excreted to
determine the polyfructosan clearance. For these studies, total
renal polyfructosan clearance was calculated using the equation
IRx[In]/[P], where JR is the infusion rate of the polyfructosan
infusion solution, [In] is the polyfructosan concentration in that
solution, and P is the steady—state polyfructosan concentration
[15]. This technique was utilized to avoid the need of bladder
catheterization and minimize the risks of repeated prolonged
anesthesia.
Analytical and statistical methods
Polyfructosan concentration was determined with an auto-
mated anthrone assay (Technicon Instrument Corp., Tarry-
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town, New York, USA). Clearance data are presented as mean
SEM. Statistical comparisons within each group were per-
formed using paired Student's t-tests. A P value of less than
0.05 was considered statistically significant.
Histology
At the completion of each experiment, the kidneys were fixed
with aortic perfusion with 1.25% glutaraldehyde in 0.1 M
cacodylate buffer, or sliced and fixed by immersion in 10%
neutral buffered formalin, and subsequently processed for light
microscopy. Paraffin sections (4 p.m) were cut and stained with
hematoxylin and eosin, and evaluated for pathological changes
(such as, cast formation, tubular injury, and necrosis and
tubular regeneration). The pathological changes were graded (in
blinded fashion) using an arbitrary scale of 0 to 4+ where 0 =no
tubular involvement, 0.5 + 0 to 10% tubular involvement, 1 +
= 10 to 25% involvement, 2+ = 25 to 50% involvement, 3+ =
50 to 75% involvement, and 4+ = >75% involvement. Gluta-
raldehyde fixed tissue was processed for ultrastructural evalu-
ation of pathologically involved areas using routine methods for
electron microscopy 1111. Immunofluorescence studies were
performed with techniques described previously 1111.
Results
Effect of the dfIferent BJPs on GFR
The effect of the different BJPs on GFR is illustrated in Figure
1 and Table 1. Administration of the p1 5.2 BJP for five days
caused the GFR to fall by 69% from 2.88 0.25 to 0.90 0.17
mI/mm. This decrement was significant at the P < 0.002 level.
Administration of the p14.3 BJP caused the GFR to decrease by
33% from 2.71 0.15 to 1.80 0.20 mllmin, a change which
was significant at the P < 0.05 level. In contrast, administration
of the p1 6.7 BJP in similar quantities and over a similar period
of time resulted in no significant change in GFR (2.93 0.11 to
2.42 0.24 mi/mm).
Effect of the different BJPs on renal histology
With light microscopy, the kidneys of all six rats given the p1
5.2 BJP were found to have extensive intratubular casts which
were localized predominantly to the thick ascending limb, and
thin limbs of Henle and the collecting tubules (Figs. 2A and 2C).
The casts were variable in consistency, some being highly
eosinophilic and homogeneous in appearance while others were
lamellated and fractured, or consisted of globular aggregates.
With electron microscopy the casts were found to be composed
(Fig. 3) of a heterogeneous mixture of highly electron—dense
material (present as individual or aggregated globules), less
electron—dense amorphous—granular material, and coarse fi-
brils. Immunofluorescence study of the casts using antibody
directed against rat light chain showed 3 to 4+ fluorescence in
a rim pattern about the casts. In addition to the cast formation,
there were several other morphologic alterations of note. As is
illustrated in Figure 2A, tubules surrounding the casts were
often dilated and the epithelia flattened. Frank tubular necrosis
was rarely noted. Evidence of sublethal tubular injury, how-
ever, was observed in the form of foamy vacuolization of
proximal tubular cells (Figs. 4A and 4B). As may be seen in
Figure 4A, the severity of this lesion was variable. With
electron microscopy (Fig, 4C), the foamy appearance of the
proximal tubules was found to be due to the presence of
numerous vacuoles, a number of which appeared to be
autophagic vacuoles containing mitochondrial remnants (Fig.
4C). Many of the mitochondria were swollen and had partial
loss of cristae. In addition, lipid droplets were frequently
observed. Other findings on the H&E stained sections included
focal areas of tubular regeneration (characterized by hyper-
chromatic nuclei and basophilic cytoplasm) involving both
proximal tubules and the collecting system, and hypertrophy
and hyperplasia of papillary collecting duct epithelia (Fig. 2C).
As is demonstrated in Figure 2C, casts were commonly ob-
served in proximity to these areas of collecting duct hypertro-
phy and hyperplasia.
Rats receiving the p1 4.3 BJP had a similar, but less promi-
nent, spectrum of hitologic alterations. Cast formation and
tubular dilatation were quantified as 1 to 2 + in the cortical
tubules and 3 to 4+ in the inner stripe of the outer medulla.
Immunofluorescence examination of these casts showed less
prominent (1 to 2+) fluorescence than was observed in the p1
5.2 group. Proximal tubule autophagic vacuoles were also
observed in the p1 4.3 group. In addition, the ultrastructural
appearance of the casts was similar to that noted above for the
p1 5.2 group.
Of the eight rats receiving the p1 6.7 BJP, five had virtually
normal renal histology (Fig. 2B, 2D and 5). In the other three,
focal areas of tubular cell regeneration and cast formation
suggestive of resolving injury were observed in the superficial
renal cortex. Unlike the other two groups, this group only
rarely had casts present in the collecting ducts.
To facilitate comparison of the pathologic changes in the
three groups, individual scores for the extent of tubular involve-
ment by cast formation and vacuolization are presented in
Figures 6 and 7. Vacuolization was most severe in the p1 5.2
group. It was present, but to a much lesser degree in the p1 6.7
group, and was of intermediate severity in the p1 4.3 group.
Cast formation was also most extensively seen in the p1 5.2
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Fig. 1. The effect of chronic administration of three different BJPs on
GFR. Pre and post refer to the GFR measured prior to and following
five days administration (100 mg/day) of the BJPs.
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Table 1. Effect of the different BJPs on GFR, mi/mm
p1 4.3 p1 5.2 p1 6.7
Pre Post Pre PostPre Post
2,92 2.18 3.05 1.18 2.73 2.13
3.03 1.39 3.79 0.90 3.30 2.83
2.48 1.53 2.65 1.60 2.62 3.42
2.43 2.11 3.23
2.30
2.27
0.43
0.49
0.81
3.08
3.08
2.95
2.43
3.30
2.42
1.81
1.58
2.27
2.91
Mean SEM 2.71 0.15 1.80 0.20k' 2.88 0.24 0.90 017b 2.94 0.11 2.42 0.24c
a P < 0.05 Post vs. Pre
b P < 0.002 Post vs. Pre
NS
group. While it was particularly extensive in the medulla, it was
also readily observed in cortical tubules. In the p1 4.3 group,
fairly severe involvement was also observed in the medulla, but
the cortical involvement was much less apparent. In the p1 6.7
group, cast formation was never extensive.
Discussion
The purpose of the present study was to further define the
importance of BJP in the genesis of myeloma—associated renal
failure and to determine if the different renal outcomes ob-
served in animals bearing different myeloma tumors (as in
patients with myeloma and Bence Jones proteinuria) were a
function of the different BJP to which the kidneys were ex-
posed. We found that renal failure could be induced with
chronic administration of certain BJPs, and that the effects on
renal morphology and function previously observed in rats
bearing different BJP synthesizing tumors [11] could, in large
part, be reproduced by the chronic administration of the dif-
ferent BJPs to non-tumor bearing rats.
Evaluation and comparison of the nephrotoxic potential of
different BJPs and delineation of the determinants of that
potential have been attempted by several authors with admin-
istration of human BJP to rats or mice [16, 17]. Conclusions
from these studies need to be somewhat guarded, however,
since heterologous BJPs were employed and renal handling of
these foreign proteins might differ from that of native proteins.
In addition, because of the possibility of an immune response to
these heterologous proteins, only acute exposure to these BJPs
could be evaluated. To circumvent these problems, we have
utilized a rat model of myeloma which was developed by Bazin,
Beckers and Heremans [18]. These investigators discovered a
unique strain of rats which spontaneously develop myeloma
protein—synthesizing tumors. These tumors can be transplanted
to a closely—related histocompatible strain of rats which do not
spontaneously develop the tumors, and each tumor cell line can
be maintained through many passages in this manner. With the
use of this model, the effects of chronic exposure of the kidney
to homologous BJP can be examined.
In our previous study, we found that rats bearing the p1 6.7
BJP synthesizing tumor survived for about 40 days, excreted up
to 150 mg/day of protein (most of which was BJP), and
maintained a normal serum creatinine and renal histology. Rats
bearing the p1 5.2 BJP synthesizing tumor survived only 15
days, excreted 30 to 60 mg/day of protein at the time of death,
and developed an elevated serum creatinine and a myeloma—
kidney cast nephropathy. The rats bearing the p1 4.3 BJP
synthesizing tumor survived about 40 days, excreted up to 200
mg of protein per day and developed a bland cast nephropathy
with tubular necrosis. Some myeloma casts, however, were
present in the medulla in this group as well.
In the present study, we found that administration of 100
mg/day of the p1 6.7 BJP for five days had little, if any, effect on
renal function and morphology. Administration of similar
amounts of the p1 5.2 BJP caused a sharp fall in the GFR and
induced a myeloma—protein containing cast nephropathy. Ad-
ministration of the p1 4.3 BJP caused a lesser, but significant,
fall in GFR and induced a cast nephropathy as well. Unlike our
study in tumor bearing rats, the animals in each group were
equally healthy, and the kidneys in each group of rats were
exposed to the same amount of the different BJP for the same
period of time. Thus, the different renal effects cannot be
ascribed to group differences in tumor burden and its conse-
quences, or amount of BJP exposure. It is possible that small
amounts of urinary proteins other than the BJP or other factors
present in the urine (which was administered daily) could be
nephrotoxic and could account, in part, for the changes that
were seen in the present study. However, these proteins were
presumably present in the material given the p1 6.7 BJP group,
and the changes in GFR in this group were only modest as were
the alterations in renal histology. Since the rats in the other two
groups were treated in the same fashion except for the BJP
which was administered, it seems reasonable to conclude that
the different results observed in the other groups were a
function of the different BJPs to which the kidneys were
exposed. Other parameters which may affect cast formation,
such as urine pH and osmolality [19], were controlled in this
study and thus could not contribute to the differences seen
among the three groups.
Several aspects regarding the morphologic alterations ob-
served in this study warrant comment. First, several morpho-
logic lesions in addition to the distal nephron cast formation—
sublethal tubular injury (vacuolar changes), tubular regenera-
tion, and collecting duct hypertrophy and hyperplasia—were
observed in this study. These lesions were most prevalent in the
p1 5.2 group and less prevalent in the p1 4.3 group. While renal
histology was largely preserved in the p1 6.7 group, all three of
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Fig. 2. Histologic sections of the medulla from rats receiving the p15.2 orpl 6.7 BJP. A. Inner stripe of outer medulla shows heterogeneous casts
in distended thick ascending limbs of Henle's loop in a rat given the p1 5.2 BJP. B. Similar region of medulla from a rat receiving the p1 6.7 BJP.
Note the absence of morphologic alterations. C. Papilla from a rat receiving the p1 5.2 BJP. The collecting duct epithelia are hypertrophicd and
hyperplastic. Casts are seen in many of the collecting tubules. D. Papilla from a rat receiving p1 6.7 BJP. The casts and collecting duct changes
noted in the p1 5.2 BJP group are not present. (Hematoxylin and Eosin, X 200).
these lesions were also present (albeit rarely) in this group as
well. Thus, these lesions did not appear to be unique for any
one of the proteins. It should be stressed, however, that while
all three groups had qualitatively similar alterations in renal
histology, the alterations were markedly different from a quan-
titative standpoint, and the three groups could be easily distin-
guished on a histologic basis. These lesions were not described
in our previous study in the tumor bearing rats 1 1]. Re-
examination of the H & E stained sections from that study,
however, revealed that these lesions were indeed present (to
variable extent) in all three of tumor bearing groups. it is of
interest that all of these lesions have also been reported in
patients with multiple myeloma 1201 and in rats given an
intraperitoneal injection of human BJP 1211. Hill [20] has
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Fig. 3. Ultrastructural appearance of cast in a collecting tubule from a rat receiving the p1 5.2 BJP. The cast is composed of a heterogeneous
mixture of granular material and dense globules. Note cell undergoing mitotic division(*). Stained with uranyl acetate and lead citrate, X 2600.
commented that vacuolar changes similar to that seen in os-
motic nephrosis are frequently observed in patients with
myeloma. While these vacuolar changes have been reported in
association with (and may be ascribed to) the administration of
intravenous radiographic contrast—media [22] and osmotic di-
uretics, the current studies suggest that this lesion may result
solely from exposure to the myeloma protein. The ultrastruc-
tural features of this lesion in myeloma patients have received
little study to date. In the present study, this lesion appeared to
represent accelerated autophagocytosis [23]. As was illustrated
in Figure 3, many of the vacuoles contained mitochondrial
remnants, and many mitochondria not enveloped in vacuoles
were abnormal appearing due to swelling and disruption of their
cristae. Other organelles appeared to be intact. Thus exposure
of some proximal tubules to BJP seemed to be associated with
mitochondrial injury and accelerated autophagy with a predi-
lection for mitochondria. It is of interest that mitochondrial
disruption and accelerated autophagy with vacuoles containing
mitochondrial remnants, similar to that described above, were
reported by Costanza and Smoller in an electron microscopic
study of renal tissue from a patient with myeloma and the
Fanconi syndrome [24]. Others have also noted alterations in
the mitochondria of proximal convoluted tubules from patients
with myeloma [25]. While this type of injury may not be unique
to myeloma protein exposure, it may be a forerunner of the
tubular atrophy that has been described in patients who have
Bence Jones proteinuria and renal insufficiency, but in whom
cast nephropathy is absent [3, 10].
Second, the renal morphologic changes observed in this
study differed somewhat from those observed in the tumor
bearing rats in our previous study. The lesions in the rats
administered the p1 5.2 BJP were more extensive and severe
than were those in the p1 5.2 BJP tumor bearing group. This
may have been a function of the amount of BJP to which the
kidney was exposed. Rats bearing the tumor excreted only 30 to
60mg of the p1 5.2 BJP per day for several days prior to study.
In the present study the rats were given 100 mg/day of the p1 5.2
BJP for five days. The renal lesion reported for the p14.3 tumor
bearing rats also differed somewhat from what was found in the
present study. While the tumor bearing rats did have distal—
nephron myeloma protein—containing casts, they also had a
bland cast nephropathy with tubular necrosis. In the present
study frank necrosis was only rarely observed. However,
proximal tubular cells were injured as reflected in the vacuolar
changes that were seen. This difference in findings may also be
a function of the amount of BJP to which the kidneys were
exposed. The tumor bearing animals excreted 150 to 200 mg/day
of the BJP for up to four weeks. In the present study the
kidneys were only exposed to 100 mg/day for five days. Thus
the increased exposure to the BJP (in our previous study) may
have amplified the degree of injury. Alternatively, other factors
present in the tumor bearing animals (but not the infused rats)
may have played a role in the genesis of this lesion. With regard
to the p1 6.7 group, six of the eight rats given the p1 6.7 BJP had
relatively little change in GFR or renal histology, while two rats
had rather marked decrements in GFR along with evidence of
tubular injury. No obvious cause for the different findings in
these two rats was apparent.
That different renal outcomes were observed with the admin-
istration of the different BJP and that these findings were in
large part similar to those observed in the respective tumor—
bearing animals provides strong evidence that BJP themselves
may be the cause of the renal lesions and that the nephrotoxic
potential of the BJP is variable. The physicochemical determi-
nant(s) of this variable BJP-dependent nephrotoxicity was not
delineated in this study. In recent years it has been postulated
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Fig. 4. Histologic section from cortex of rot given the p15.2 BJP. A,
Casts are seen in distal nephron segments (*) Vacuolar alterations,
present in most proximal tubular segments in this field, are
particularly extensive in certain segments (arrows). (Hematoxylin and
Eosin, x 200). B. Toluidine blue stained plastic section showing
higher resolution and more apparent vacuolar changes than can be
seen in Figure 4A. Also note collecting tubule (C) filled with a dense
cast. x 300. C. Ultrastructural appcarancc of proximal tubule cell
with vacuolar changes. Note loss of cristac and rarcfication of
mitochondrial matrix (M) as well as vacuoles (V) containing
mitochondrial remnants in varying stages of dissolution, Lipid
droplets (L) are also present (x 10,000).
*
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Fig. 5. Histologic sections of cortex from a rat receiving the p16.7 BJP. A. Normal histologic appearance is seen in this hematoxylin and eosin
stained paraffin section. x 200. B. Toluidine blue stained plastic sections demonstrate the absence of the extensive vacuolar alterations which were
observed in the rats receiving the p1 5.2 BJP (Fig. 4B)'(x 300).
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Fig. 6. Extent of vacuolization found in the rats given p16.7, p1 5.2, or regions of kidneys given p16.7, p1 5.2, or p14.3 BJP.
p14.3 BJP.
BJP with low p1's (anionic) were non-nephrotoxic. Compatible
that the nephrotoxic potential of a given BJP may be a function with this idea were the findings of Clyne, Pesce and Thompson
of the net electric charge of the BJP. It was suggested that BJP [16]. They administered a variety of human BJP acutely to
with high p1 (and therefore cationic) were nephrotoxic while hydropenic, aciduric rats and found that cast formation and
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renal failure developed primarily in the rats which received the
cationic BJPs. Clinical studies designed to address this hypoth-
esis have yielded somewhat conflicting results. While Coward
et a! [4] found a negative correlation between the p1 of the BJP
and the creatinine clearance in 23 patients, Melcion and co-
workers [261 observed, in a study of 17 patients, that both
anionic and cationic BJP were associated with nephrotoxicity.
Under the conditions of the present study (urine pH = 5.5 to
6.0) the p1 4.3 and 5.2 BJPs were anionic and p1 6.7 BJP was
cationic. Thus, in this study the anionic BJP were nephrotoxic
and cationic BJP were not. Using another animal model, Weiss
et al showed that anionic BJP may be nephrotoxic [27]. Taken
together, these findings suggest that the nephrotoxicity of a BJP
may be dissociated from its net electric charge and indicate that
factors other than electric charge are important in determining
the nephrotoxic potential of BJP.
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